• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

MorphoSys AG. (11/7/13). "Press Release: MorphoSys AG Reports Results for the First Nine Months of 2013".

	Organisation	MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY)
	Group	MorphoSys (Group)
	Organisation 2	MorphoSys AbD GmbH (AbD Serotec)
	Today	Bio-Rad AbD Serotec GmbH
	Group	Bio-Rad (Group)
	Product	MOR103/GSK3196165 (MorphoSys/GSK)
	Product 2	HuCAL®
	Index term 2	Celgene–MorphoSys: antibody cancer drug, 201306–201503 collab strat alliance up to €628m incl €70.8m upfront acqu ww rights to MOR202 TERMINATED 3/15
	Person	Moroney, Simon E. (MorphoSys 1992– CEO + Founder)
	Person 2	Holstein, Jens (MorphoSys 201105– CFO before Regional CFO Fresenius Kabi + Managing Director Fresenius Kabi Deutschland)

Record changed: 2017-04-02

Advertisement

More documents for MorphoSys (Group)

• [1] MorphoSys AG. (4/23/18). "Press Release: MorphoSys Announces Closing of Nasdaq IPO through an ADS Offering and Exercise of the Underwriters' Option to Purchase Additional ADSs, Leading to Total Gross Proceeds of USD 239 million". Planegg....
• [2] MorphoSys AG. (4/18/18). "Press Release: Ad hoc – MorphoSys Resolves a Capital Increase to Implement the Offering of 8,300,000 American Depositary Shares (ADS) in the United States". Planegg....
• [3] MorphoSys AG. (4/18/18). "Press Release: MorphoSys Announces Pricing of Initial Public Offering of American Depositary Shares (ADSs) on Nasdaq". Planegg....
• [4] MorphoSys AG. (4/10/18). "Press Release: MorphoSys Nominates New Candidates for Supervisory Board". Planegg....
• [5] MorphoSys AG. (4/9/18). "Press Release (Ad hoc): MorphoSys Announces Launch of American Depositary Shares (ADS) Offering in the United States"....
• [6] MorphoSys AG. (4/6/18). "Press Release: MorphoSys Announces Approval of Tremfya (Guselkumab) for the Treatment of Moderate to Severe Forms of Psoriasis and Psoriatic Arthritis in Japan". Planegg....
• [7] MorphoSys AG. (3/22/18). "Press Release (Ad hoc): MorphoSys Files Registration Statement in the United States for a Proposed American Depositary Shares (ADS) Offering". Planegg....
• [8] Selvita S.A.. (2/6/18). "Press Release: Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer". Kraków....
• [9] MorphoSys AG. (11/30/17). "Press Release: MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab". Planegg....
• [10] MorphoSys AG. (11/23/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received Approval for Tremfya (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis". Planegg....

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2018. Made in Germany.